Clinical Trial Update: Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 clinical trial evaluating subcutaneous adalimumab in adult Chinese rheumatoid arthritis patients treated with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Abbott | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED